Skip to content

Sustainable Household Energy Adoption in Rwanda (SHEAR)

Sustainable Household Energy Adoption in Rwanda (SHEAR): Promoting Rural Health With Solar and Natural Gas

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05668624
Acronym
SHEAR
Enrollment
1680
Registered
2022-12-30
Start date
2022-11-17
Completion date
2025-08-22
Last updated
2026-01-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blood Pressure, Lung Function

Brief summary

Investigators will conduct a randomized controlled trial substituting traditional forms of household energy (biomass for cooking and kerosene for lighting) with liquified petroleum gas (LPG) stoves/fuel and solar power (in areas marker for solar grids by the Government of Rwanda) in rural Rwanda. Eligible households (n=650) using traditional forms of energy will be recruited from eastern Rwanda. In each household, investigators will recruit either one adult female and one adult male or just one adult, and one child (aged 8-15 years). Following baseline health and exposure assessment, a randomized treatment arm (n=250 homes) will receive a full subsidy for LPG fuel and solar power, a control arm (n=250 homes) will continue to use traditional energy, and a random-subsidy arm (n=150 homes) will be randomized to a discounted price (at baseline and every 6-months) for solar and LPG in a pay-as-you-go (PAYG) service model (i.e., pre-pay a desired amount through mobile money). The random subsidy arm will then decide whether or not to cook with the discounted LPG or their traditional stove. Participants will be followed for 3 years with repeated measures of household air pollution (HAP) exposure (48-hour fine particulate matter (PM2.5) and black carbon (BC)), energy use, health, and preferences. Primary health endpoints include blood pressure (BP) in adults and lung-function growth in children; secondary endpoints include BP in children and lung-function change in adults. To complement the trial, the random-subsidy arm will generate policy-relevant information on causal relationships between energy costs, solar and LPG usage, and HAP exposures. The investigators propose 3 aims: Aim 1. In an ITT framework, investigators will evaluate the effect of a household energy intervention on exposure to HAP and indicators of morbidity separately among Rwandan women, men, and children within n=500 households. Aim 2. Using exposure-response modeling, investigators will characterize associations between exposure to HAP and indicators of morbidity separately among Rwandan women, men, and children within n=650 households (500 trial households + 150 random subsidy households). Aim 3. Using a random-encouragement design, investigators will investigate causal relationships between randomized energy costs, measured energy usage, and estimated exposure to HAP among n=400 households (150 random subsidy households + 250 full subsidy treatment arm households).

Interventions

OTHERClean household energy

LPG stoves/fuel for cooking and solar electricity for lighting

Sponsors

National Institute of Environmental Health Sciences (NIEHS)
CollaboratorNIH
Colorado State University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
8 Years to No maximum
Healthy volunteers
No

Inclusion criteria

This research will recruit and enroll 650 households (250 households in the full subsidy arm; 250 households in the control arm; 150 households in the discount subsidy arm). The household level inclusion criteria is as follows: * Home resides in the study area of Isangano and Karambi * Uses biomass as primary cooking fuel * Either both an adult male (at least 18 years old) and female (at least 18 years old), or just one adult (at least 18 years old), head(s) of household willing to consent and at least one child between 8 and 15 years of age willing to assent; We will recruit the younger child in families with more than one child between 8-15 years of age. We will also confirm the child is living at home throughout the year and not attending boarding school elsewhere. * No commercial cooking * No smoking in the household Additional participant level inclusion is as follows: * Not planning to move in 3-year timeframe * Not currently pregnant (females); Note: If the female becomes pregnant during the study she will not be able to participate in any visits that occur during her pregnancy but she will be able to participate after she has given birth. However, if there is another adult in the household then this will not preclude the other two people (i.e., the other adult and the child) from continuing to participate throughout that time.

Exclusion criteria

The household level

Design outcomes

Primary

MeasureTime frame
Change in systolic blood pressure (adults)Blood pressure will be measured approx. every 6 months for the 3-year follow-up period
Spirometry (children): FEV1 trajectorySpirometry will be measured approx. every 6 months for the 3-year follow-up period
Spirometry (children): FVC trajectorySpirometry will be measured approx. every 6 months for the 3-year follow-up period

Secondary

MeasureTime frame
Spirometry (children): FEF25-75 trajectorySpirometry will be measured approx. every 6 months for the 3-year follow-up period
Spirometry (children): PEF trajectorySpirometry will be measured approx. every 6 months for the 3-year follow-up period
Change in diastolic blood pressure (adults)Blood pressure will be measured approx. every 6 months for the 3-year follow-up period
Spirometry (adults): FEV1 changeLung function will be measured approx. every 1 year for the 3-year follow-up period (adults).
Change in systolic blood pressure (children)Blood pressure will be measured approx. every 6 months for the 3-year follow-up period
Spirometry (adults): FEV1/FVC changeLung function will be measured approx. every 1 year for the 3-year follow-up period (adults).
Spirometry (adults): FEF25-75 changeLung function will be measured approx. every 1 year for the 3-year follow-up period (adults).
Spirometry (adults): PEF changeLung function will be measured approx. every 1 year for the 3-year follow-up period (adults).
Spirometry (adults): FVC changeLung function will be measured approx. every 1 year for the 3-year follow-up period (adults).
Change in diastolic blood pressure (children)Blood pressure will be measured approx. every 6 months for the 3-year follow-up period
Spirometry (children): FEV1/FVC trajectorySpirometry will be measured approx. every 6 months for the 3-year follow-up period

Countries

Rwanda

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 7, 2026